The latent membrane protein 1 of Epstein-Barr virus and loss of the INK4a locus:: paradoxes resolve to cooperation in carcinogenesis in vivo

被引:11
作者
Macdiarmid, J [1 ]
Stevenson, D [1 ]
Campbell, DH [1 ]
Wilson, JB [1 ]
机构
[1] Univ Glasgow, Inst Biomed & Life Sci, Div Mol Genet, Glasgow G11 6NU, Lanark, Scotland
关键词
GROWTH-FACTOR RECEPTOR; NASOPHARYNGEAL CARCINOMA; MEMBRANE-PROTEIN; TRANSGENIC MICE; EPITHELIAL-CELLS; SUSCEPTIBILITY LOCUS; ENCODED LMP1; SKIN TUMORS; HIGH-RISK; P16; GENE;
D O I
10.1093/carcin/bgg070
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nasopharyngeal carcinoma (NPC) is the most tightly Epstein-Barr virus (EBV)-associated tumour. The EBV oncoprotein latent membrane protein 1 (LMP1) is frequently expressed in NPC tumours and may play a role in the genesis of the disease. NPC tumours often exhibit loss of expression (by deletion or methylation) of the INK4a locus, which encodes the tumour suppressor genes p16(INK4a) and p14(ARF). To investigate the contribution of LMP1 and INK4a loss to tumourigenesis, skin chemical carcinogenesis was conducted using PyLMP1 and INK4a null mice. Surprisingly, INK4a null mice developed significantly fewer papillomas than wild-type mice, nevertheless, the papillomas that did develop grew faster and converted more rapidly to carcinoma than controls. This indicates that while loss of the INK4a locus plays an important role in the later stages of tumourigenesis, initially its loss inhibits papilloma formation. Conversely, LMP1 promoted papilloma formation but paradoxically inhibited papilloma growth. Using cross-breeds, it was found that LMP1 cooperates with loss of the INK4a locus during epithelial tumourigenesis. The expression of LMP1 overcame the inhibition of papilloma formation observed in INK4a null mice, whilst the loss of the INK4a locus counteracted the inhibition of papilloma growth rate found in PyLMP1 mice. This suggests that LMP1 mediates the inhibition of papilloma growth via one or both of the INK4a locus products. Intriguingly, mice heterozygous for INK4a loss showed lesion growth rates intermediate between wildtype and null, demonstrative of haploinsufficiency. We propose that LMP1 acts at the early stages in carcinogenesis to promote the development of benign tumours and that early reduction of INK4a locus expression allows these lesions to expand in size. In addition, loss of the INK4a locus accelerates the development of a more aggressive lesion. Conversely, complete loss of the INK4a locus in an otherwise normal cell might inhibit lesion formation.
引用
收藏
页码:1209 / 1218
页数:10
相关论文
共 58 条
[21]  
Horikawa T, 2000, CANCER-AM CANCER SOC, V89, P715, DOI 10.1002/1097-0142(20000815)89:4<715::AID-CNCR1>3.0.CO
[22]  
2-9
[23]  
Huang D P, 1978, IARC Sci Publ, P315
[24]  
HUANG DP, 2002, EPSTEINBARR VIRUS RE, V9, P43
[25]  
*IARC, 1997, IARC MON EV CARC RIS, V70
[26]   No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours [J].
Jefferies, S ;
Edwards, SM ;
Hamoudi, RA ;
A'Hern, R ;
Foulkes, W ;
Goldgar, D ;
Collaborators, MPT ;
Eeles, R .
BRITISH JOURNAL OF CANCER, 2001, 85 (09) :1383-1386
[27]   EPSTEIN-BARR-VIRUS LATENT MEMBRANE PROTEIN-1 IS ESSENTIAL FOR B-LYMPHOCYTE GROWTH TRANSFORMATION [J].
KAYE, KM ;
IZUMI, KM ;
KIEFF, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) :9150-9154
[28]   The amino-terminus and membrane-spanning domains of LMP-1 inhibit cell proliferation [J].
Kaykas, A ;
Sugden, B .
ONCOGENE, 2000, 19 (11) :1400-1410
[29]   REDUCTION OF P53 GENE DOSAGE DOES NOT INCREASE INITIATION OR PROMOTION BUT ENHANCES MALIGNANT PROGRESSION OF CHEMICALLY-INDUCED SKIN TUMORS [J].
KEMP, CJ ;
DONEHOWER, LA ;
BRADLEY, A ;
BALMAIN, A .
CELL, 1993, 74 (05) :813-822
[30]  
Le Roux F, 1998, EPSTEINBARR VIRUS RE, V5, P53